MRI Scan and Intra-labyrinthine Schwannoma
Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Unknown status
CT.gov ID
NCT03580850
Collaborator
(none)
30
1
12
2.5
Study Details
Study Description
Brief Summary
Evaluate the interest of gadolinium for the positive and topographic diagnosis of intra-labyrinthine schwannoma, comparing T1 sequence acquired after gadolinium injection to a sequence of fast imaging type employing steady state acquisition (FIESTA-C)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
30 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
INTEREST OF INTRAVENOUS INJECTION OF GADOLINIUM IN EXPLORATION INTRA-LABYRINTHINE SCHWANNOMA IN MRI 3 TESLAS
Actual Study Start Date
:
Feb 2, 2018
Anticipated Primary Completion Date
:
Feb 1, 2019
Anticipated Study Completion Date
:
Feb 1, 2019
Outcome Measures
Primary Outcome Measures
- Presence or absence of intra labyrinthine vestibular nerve tumor using T2 FIESTA alone [1 hour after the realization of the MRI]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Age 18-80 years
-
Have intra-labyrinthine schwannoma
-
Have benefited from an MRI with gadolinium injection on the MRI 3T with interpretable sequences of good quality
-
Subject giving their consent for their participation
-
Subjects who benefited, between 2009 and 2016, from an MRI of the external auditory canals, with gadolinous product injection and on the 3 Tesla MRI, in which a diagnosis of intra labyrinthine schwannoma was made
Exclusion Criteria:
- Refusal to participate in the study
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Service Imagerie 1 | Strasbourg | France | 67098 |
Sponsors and Collaborators
- University Hospital, Strasbourg, France
Investigators
- Study Director: Francis VEILLON, MD, PhD, University Hospital, Strasbourg, France
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT03580850
Other Study ID Numbers:
- 6809
First Posted:
Jul 9, 2018
Last Update Posted:
Jul 13, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms: